Skip Navigation

Publicaciones covid-9

SARS-CoV-2 Lambda variant exhibits higher infectivity and immune resistance

Izumi Kimura, Yusuke Kosugi, Jiaqi Wu, Daichi Yamasoba, Erika P Butlertanaka, Yuri L Tanaka, Yafei Liu, Kotaro Shirakawa, Yasuhiro Kazuma,
Ryosuke Nomura, Yoshihito Horisawa, Kenzo Tokunaga, Akifumi-Takaori Kondo, Hisashi Arase, The Genotype to Phenotype Japan (G2P-Japan)
Consortium, Akatsuki Saito, So Nakagawa, Kei Sato
?  Evaluación: (not yet rated)
Resumen

SARS-CoV-2 Lambda, a new variant of interest, is now spreading in some South American countries; however, its virological features and evolutionary trait remain unknown. Here we reveal that the spike protein of the Lambda variant is more infectious and it is attributed to the T76I and L452Q mutations. The RSYLTPGD246-253N mutation, a unique 7-amino-acid deletion mutation in the N-terminal domain of the Lambda spike protein, is responsible for evasion from neutralizing antibodies. Since the Lambda variant has dominantly spread according to the increasing frequency of the isolates harboring the RSYLTPGD246-253N mutation, our data suggest that the insertion of the RSYLTPGD246-253N mutation is closely associated with the massive infection spread of the Lambda variant in South America.

Procedencia del autor
Texto completo
Tipo de documento
Especialidad(es)
Publicado en el sitio 2021-08-20 17:58:53

Comentarios

(aún no hay comentarios disponibles para este recurso)